Error message

The page you requested does not exist. For your convenience, a search was performed using the query Surgical Oncology.

Page not found

Search results

  1. The Road to the Clinic for Small Molecule

    for Neuroscience, Oncology (until 2013), Infectious Diseases including Vaccines, and, since 2013, Global Public ... of compounds in internal medicine, CNS and oncology, both in early and late stages of clinical development. His ... oncology and anti-infectives within Janssen/Centocor, Eisai and Aventis. Currently, she is leading multiple ...

  2. The Road to the Clinic for Small Molecule

    for Neuroscience, Oncology (until 2013), Infectious Diseases including Vaccines, and, since 2013, Global Public ... of compounds in internal medicine, CNS and oncology, both in early and late stages of clinical development. His ... oncology and anti-infectives within Janssen/Centocor, Eisai and Aventis. Currently, she is leading multiple ...

  3. The Road to the Clinic for Small Molecule

    for Neuroscience, Oncology (until 2013), Infectious Diseases including Vaccines, and, since 2013, Global Public ... of compounds in internal medicine, CNS and oncology, both in early and late stages of clinical development. His ... oncology and anti-infectives within Janssen/Centocor, Eisai and Aventis. Currently, she is leading multiple ...

  4. [London, UK] The Road to the Clinic for Small Molecule

    for Neuroscience, Oncology (until 2013), Infectious Diseases including Vaccines, and, since 2013, Global Public ... pharmacology development aspects of compounds in internal medicine, CNS and oncology, both in early and late ... focus on rheumatology, oncology and anti-infectives within Janssen/Centocor, Eisai and Aventis. ...

  5. [Heidelberg, DE] The Road to the Clinic for Small Molecule

    for Neuroscience, Oncology (until 2013), Infectious Diseases including Vaccines, and, since 2013, Global Public ... of compounds in internal medicine, CNS and oncology, both in early and late stages of clinical development. His ... oncology and anti-infectives within Janssen/Centocor, Eisai and Aventis. Currently, she is leading multiple ...

  6. [Heidelberg, DE] The Road to the Clinic for Small Molecule

    for Neuroscience, Oncology (until 2013), Infectious Diseases including Vaccines, and, since 2013, Global Public ... of compounds in internal medicine, CNS and oncology, both in early and late stages of clinical development. His ... oncology and anti-infectives within Janssen/Centocor, Eisai and Aventis. Currently, she is leading multiple ...

  7. [London, UK] The Road to the Clinic for Small Molecule

    for Neuroscience, Oncology (until 2013), Infectious Diseases including Vaccines, and, since 2013, Global Public ... pharmacology development aspects of compounds in internal medicine, CNS and oncology, both in early and late ... focus on rheumatology, oncology and anti-infectives within Janssen/Centocor, Eisai and Aventis. ...

  8. [Heidelberg, DE] The Road to the Clinic for Small Molecule

    for Neuroscience, Oncology (until 2013), Infectious Diseases including Vaccines, and, since 2013, Global Public ... of compounds in internal medicine, CNS and oncology, both in early and late stages of clinical development. His ... oncology and anti-infectives within Janssen/Centocor, Eisai and Aventis. Currently, she is leading multiple ...

  9. [San Antonio TX session] Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck

    through Phase II programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His ...

  10. The Doctor Will "Tweet" You Now

    in audience-based, agile analytics. Meredith’s client work includes Takeda Oncology, Amgen, Sanofi Diabetes, UCB, ...

Pages

Share